摘要:
The present invention provides novel N-alkyl-N-phenylhydroxylamine derivatives containing metal chelating groups, a process for preparing the same, the use of the novel compounds as therapeutics for treating and/or preventing various medical dysfunctions and diseases arising from reactive oxygen species (ROS) and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease. The compounds of the invention possess similar or superior LPO inhibition activity to the reference compounds of Trolox and Ebselen. While showing lower toxicity, they also effectively inhibit the cerebral neuronal cell death caused by ROS and/or zinc ion, and show neuroprotective effects against ischemic neuronal degeneration.
摘要:
The amorphous perovskite structure catalysts according to the present invention comprise a carrier material and a mixture of at least two metal oxides supported thereon, which have the following formula: (M.sup.1.sub.a O.sub.x.M.sup.2.sub.1-a O.sub.y)(M.sup.3.sub.b O.sub.z.M.sup.4.sub.1-b O.sub.w)/S wherein M.sup.1 and M.sup.2 independently of each other are selected from the group consisting of the lanthanide metals, the alkali metals and the alkaline earth metals, M.sup.3 and M.sup.4 independently of each other are selected from the group consisting of the transition metals and the platinum metals, a and b are from 0 to 1, x, y, z and w are determined stoichiometrically on the values of a and b, the ratio of �M.sup.1 +M.sup.2 ! to �M.sup.3 +M.sup.4 ! is 0.1.about.3.0:1.0, and S is a carrier material. The process for preparing the amorphous perovskite structure catalysts comprises dissolving completely at least two salt solutions of metals, M.sup.1, M.sup.2, M.sup.3 and M.sup.4, and an acid in an organic acid, preparing an ester type resin intermediate by adding a hydroxy alcohol to the solution, mixing the solution in a liquid state by adding a powder type carrier material, distilling the mixed solution under a reduced pressure so as to concentrate the solution into a high viscous state, drying the concentrated solution using a microwave into a gel type catalyst precursor, and calcining the precursor stepwise at the temperatures of 300.degree..about.700.degree. C. The process can provide amorphous perovskite structure catalysts having a high specific surface area and a good dispersion for denitrizing nitrogen oxides.
摘要:
A method for managing energy in a sensor network environment using a spanning tree includes the steps of collecting amount of remaining energy of nodes at a predetermined cycle by a base station in a region having a number of clusters a number of nodes forming a spanning tree in each cluster; assigning a number of links for connecting the nodes to each cluster; determining a maximum number of allowable links of the nodes; and updating the spanning tree based on the maximum number of allowable links.
摘要:
It relates to a method for removing a surfactant, organic materials and chlorine ions remained on the surface of metal nanoparticles, prepared on an organic solvent phase including a surfactant. The method for cleaning metal nanoparticles herein is efficient to remove organic materials or chlorine ions remained on the surface of the nanoparticles. Not less than 90% of impurities may be removed by this method. As a result, the thickness of a multi layer ceramic capacitor (MLCC) can be reduced and a packing factor can be improved so that it allows thinner multi layer ceramic capacitors and improved utilities of metal nanoparticles as fuel cell catalysts, hydrogenation reaction catalysts, alternative catalysts of platinum (Pt) in chemical reactions and the like.
摘要:
An apparatus for attaching substrates includes an upper chamber for holding an upper substrate and a lower chamber for holding a lower substrate which is to be attached to the upper substrate. The lower chamber is moved up and down so as to come together with the upper chamber to form a sealed attaching space. A substrate receiving part is fixed to a frame of the apparatus so that it does not move as the lower chamber is raised and lowered. The substrate receiving part alternatively projects from the lower chamber is the lower chamber is moved down, or is recessed into the top of the lower chamber when the lower chamber is lifted up.
摘要:
An apparatus for attaching substrates includes an upper chamber for holding an upper substrate and a lower chamber for holding a lower substrate which is to be attached to the upper substrate. The lower chamber is moved up and down so as to come together with the upper chamber to form a sealed attaching space. A substrate receiving part is fixed to a frame of the apparatus so that it does not move as the lower chamber is raised and lowered. The substrate receiving part alternatively projects from the lower chamber is the lower chamber is moved down, or is recessed into the top of the lower chamber when the lower chamber is lifted up.
摘要:
An apparatus for attaching substrates includes an upper chamber for holding an upper substrate and a lower chamber for holding a lower substrate which is to be attached to the upper substrate. The lower chamber is moved up and down so as to come together with the upper chamber to form a sealed attaching space. A substrate receiving part is fixed to a frame of the apparatus so that it does not move as the lower chamber is raised and lowered. The substrate receiving part alternatively projects from the lower chamber is the lower chamber is moved down, or is recessed into the top of the lower chamber when the lower chamber is lifted up.
摘要:
An apparatus for attaching substrates includes an upper chamber for holding an upper substrate and a lower chamber for holding a lower substrate which is to be attached to the upper substrate. The lower chamber is moved up and down so as to come together with the upper chamber to form a sealed attaching space. A substrate receiving part is fixed to a frame of the apparatus so that it does not move as the lower chamber is raised and lowered. The substrate receiving part alternatively projects from the lower chamber is the lower chamber is moved down, or is recessed into the top of the lower chamber when the lower chamber is lifted up.
摘要:
Provided are a node device and a method for deciding a shortest path using a spanning tree. The node device includes: a node division unit dividing the node device into sub-nodes as many as the number of nodes connected to the node device when the node device operates an edge node that is located at an end of a backbone network and is in charge of reformatting and routing frames; a spanning tree generation unit generating as many spanning trees as the number of sub-nodes, wherein each of the spanning trees comprises a shortest path to reach the other edge nodes constructing the backbone network from each of the sub-nodes; and a first path decision unit deciding a shortest path from a source node to a predetermined destination node, as a path to be used, based on the spanning trees that are generated by the spanning tree generation unit. The shortest path that is obtained based on the plurality of spanning trees is used as a path to be used such that throughput of traffic is 3 times and 1.5 times larger than in existing STP and SPB, respectively, and the transmission delay is smaller than in existing STP and SPB. In addition, packet loss is smaller than in STP and SPB, and the node device and the method for deciding a shortest path using a spanning tree are robust to the unbalanced traffic.
摘要:
A yeast extract or yeast-derived bioactive peptide having an activity of selectively inhibiting reuptake of serotonin and norepinephrine, which can be effectively used in preventing or treating various diseases related to reuptake of serotonin and norepinephrine, especially depression, anxiety, stress, fatigue and obesity is provided. Also, a yeast extract or yeast-derived bioactive peptide having activities as an anti-stress agent, an anti-fatigue agent, premenstrual syndrome (PMS) and menstrual pain relaxants, and a brain-neurotrophic factor, and a method for preparing the bioactive peptide is provided. The yeast extract or yeast-derived bioactive peptide is effective in relieving stress, nervousness, anxiety, tension, insomnia, fatigue, and imbalance in the autonomic nerve regulation. Therefore, the yeast extract or yeast-derived bioactive peptide is available as an anti-depression agent, an anti-anxiety agent, an anti-stress agent, an anti-fatigue agent, an anti-obesity agent, premenstrual syndrome and menstrual pain relaxants, a brain-neurotrophin, and a source of active foods having these activities.